Kari L. Ring

Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs

Cancer statistics, 2022

Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice

Cancer statistics, 2023

Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again

Cancer statistics, 2020

Cancer Statistics, 2021

Macrophages in immunoregulation and therapeutics

Rethinking mechanisms, diagnosis and management of endometriosis

Active immunization combined with cisplatin confers enhanced therapeutic protection and prevents relapses of HPV-induced tumors at different anatomical sites

Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Inflammation and tumor progression: signaling pathways and targeted intervention

Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression

Cervical cancer

Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

Current and emerging treatment options for endometriosis

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

Endometrial cancer: Not your grandmother's cancer

Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma

Role of Minimally Invasive Surgery in Gynecologic Oncology

Potential immunotherapy targets in recurrent cervical cancer

Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies

Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors